Life Sciences Market Research Reports

"...... during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 10......"

"...... ndustry include Danaher, Eppendorf, GE Healthcare, Parker Hannifin, Thermo Fisher Scientific, Corning, Merck, Lonza- Pharma & Biotech and Boehringer Ingelheim Pharma GmbH & Co.KG,, etc. Among those companies, the top 3 players guaranteed % supply wor......"

"...... vice industry include Illumina, Qiagen N.V., PerkinElmer, Eurofins Scientific S.E., Macrogen, LGC Limited, GENEWIZ, Beijing Genomics Institute and SciGenom Labs, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022......."

"...... xicity Testing industry include SGS SA, Covance, Bio-Rad Laboratories, QIAGEN, GE Healthcare, Eurofins Scientific SE, Merck KGaA, Thermo Fisher Scientific and Charles River Laboratories, etc. Among those companies, the top 3 players guaranteed % supp......"

"...... vices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increa......"

"...... rket for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent year......"

"...... o Fisher ScientificInc, PerkinElmer, F. Hoffmann-La Roche, Agilent Technologies, Merck KGAA, QIAGEN, Bio-Rad Laboratories, Inc. and Promega Corporation, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022. When ......"

"...... ith a compound annual growth rate of 5% expected in the next six years. Global health care expenditure currently accounts for approximately 10% of global GDP, and the proportion will continue to increase in the next few years. This is primarily due t......"

"...... ith a compound annual growth rate of 5% expected in the next six years. Global health care expenditure currently accounts for approximately 10% of global GDP, and the proportion will continue to increase in the next few years. This is primarily due t......"

"...... in 2023, with a compound annual growth rate of 5% expected in the next six years. Global health care expenditure currently accounts for approximately 10% of global GDP, and the proportion will continue to increase in the next few years. This is prima......"